The weird, the wild, and the wonderful
Following the ESMO Breast Cancer conference in Berlin this weekend, we have some data we’d like to draw your attention to.
These are also key topics for discussion in the broader context of what’s happening in advanced breast cancer and where the field is (or perhaps ought to be) heading next.
To continue reading our latest highlights on oncology new product development including commentary and analysis, BSB subscribers can log-in or you can click to access the content.
This content is restricted to subscribers